AstraZeneca used ‘outdated and potentially misleading data’ that overstated the effectiveness of its vaccine, independent panel says

by

The company and Oxford University had announced Monday that a clinical trial in the United States, Chile and Peru showed 79 percent efficacy.

View original article
Contributor: Carolyn Y. Johnson